Goal Indicator definition

Goal Indicator measures the economic growth and poverty reduction that occurs during or after implementation of the program. This is typically a direct measure of local income. Measurement of the Goal Indicator is attempted in all MCC compacts and is therefore not listed in the table below.
Goal Indicator shall have the meaning set forth in Section 2(a) of Xxxxx XXX. Governing Documents shall have the meaning set forth in Section 3(d)(i) of Annex I. Government shall have the meaning set forth in the Preamble. Government Affiliate means an Affiliate, ministry, bureau, department, agency, government corporation or any other entity chartered or established by the Government or any local government in El Salvador. References to Government Affiliate shall include any of their respective directors, officers, employees, affiliates, contractors, sub-contractors, grantees, sub-grantees, representatives, and agents. Government Members shall have the meaning set forth in Section 3(d)(ii)(2)(A) of Xxxxx X. Government Party shall have the meaning set forth in Section 3.18(e)(i). Government Responsibilities shall have the meaning set forth in Section 3.12(a). Human Development Objective shall have the meaning set forth in Section 1.1(a).
Goal Indicator means the Compact Goal Indicator of the M&E Plan that will measure the impact of the Program on the incomes of the Beneficiaries. A table of Goal Indicator definitions is set forth at Section 2(a)(i) of Annex III.

Examples of Goal Indicator in a sentence

  • Security Goal Indicator Trees (SGIT) [4] focus on positive features of the software which can be verified during the inspection process.

  • Security Goal Indicator Trees: A Model of Software Features that Supports Efficient Security Inspection.

  • United Nations, Sustainable Development Goal Indicator 16.2.1 Metadata.

  • For each Project Outcome Indicator, Project Objective Indicator, and Goal Indicator, the M&E Plan will define a strategy for obtaining and verifying the value of the Baselines.

  • It presents a suite of food security indicators including the Millennium Development Goal Indicator 1.9 on the prevalence of undernourishment at the national and sub national levels.

  • OUTPUT GOALS FOCUSSING ON THE AVERAGE LEVEL OF EDUCATIONAL QUALITY Goal Indicator Baseline and targets - 7 Improve the Average Grade 6 2009 (baseline): 495 average; languages result performance in obtained in SACMEQ.

  • Students must enter the building or playground (as allowed by school staff) immediately after leaving their vehicle or bus.

  • Table 3 Achievement of Overall Goal at the time of the Ex-post Evaluation Overall Goal Indicator Target Value (2020)Actual Value at the project completion (2015)Ratio of Actual Value in 2016 to Target Value(%)Actual Value at the Ex-post Evaluation (2018)Ratio of Actual Value in 2018 to Target Value(%) 1Proportion of clients receiving first trimester9056.963.26370 ANCMNHservices in2Proportion of clients receiving skilled delivery inUW Region856272.968.780.8 UW Region is continuously improved.

  • This book chapter focuses on the Security Goal Indicator Tree application for eliminating existing shortcomings, the training that led to their creation in an industrial project environment, their usage, and their reuse by a team in industry.

  • See infra Part III.A. Plaintiffs, however, recognize it as the hallmark of a Sherman Act violation.


More Definitions of Goal Indicator

Goal Indicator shall have the meaning set forth in Section 2(a) of Annex III. Governance Agreement shall have the meaning set forth in Section 4.1(b).

Related to Goal Indicator

  • Initial Indication means the treatment of Netherton Syndrome in humans in the Territory.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Performance Indicator means a measure of HSP performance for which a Performance Target is set; technical specifications of specific Performance Indicators can be found in the MSAA Indicator Technical Specifications document;

  • Licensed Compound means (a) 3,4-Diaminopyridine, the chemical structure of which is set forth on Exhibit B-2; and (b) any derivatives, isomers, metabolites, prodrugs, acid forms, base forms, salt forms, or modified versions of such compound in (a).

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • geographical indication , in relation to goods, means an indication which identifies such goods as agricultural goods, natural goods or manufactured goods as originating, or manufactured in the territory of a country, or a region or locality in that territory, where a given quality, reputation or other characteristic of such goods is essentially attributable to its geographical origin and in case where such goods are manufactured goods one of the activities of either the production or of processing or preparation of the goods concerned takes place in such territory, region or locality, as the case may be.

  • Development Milestone Event shall have the meaning set forth in Section 9.2(a).

  • Diagnostic Product means In Vitro Diagnostics, In Vivo Diagnostic Agents and any product used for Diagnosis.

  • New Product means the Synology-branded hardware product and Synology-branded accessories contained in the original packaging Customer bought from an authorized Synology distributor or reseller. You may see our “New Product” at Product Support Status.

  • Additional Indication means any indication other than the Initial Indication.

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Licensed Product means any method, process, composition, product, service, or component part thereof that would, but for the granting of the rights set forth in this Agreement, infringe a Valid Claim contained in the Licensed Patents.

  • Monitoring Indicator means a measure of HSP performance that may be monitored against provincial results or provincial targets, but for which no Performance Target is set;

  • Product Candidate means each of MYO-101, MYO-102, MYO-103, MYO-201 and MYO-301, as defined on Exhibit B, in each case in any form or formulation.

  • Performance Indicators means the indicators for Project monitoring and evaluation set forth in the Operational Manual.

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Development Milestone Payment shall have the meaning set forth in Section 9.2(a).

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Anti-Static Product means a product that is labeled to eliminate, prevent, or inhibit the accumulation of static electricity. “Anti-Static Product” does not include “Electronic Cleaner,” “Floor Polish or Wax,” “Floor Coating,” and products that meet the definition of “Aerosol Coating Product” or “Architectural Coating.”

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Collaborating physician means the physician who,

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.